logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 22
  • 1
    Williams, Andrew James, Dr
    Doctor born in June 1949
    Individual (1 offspring)
    Officer
    1999-05-28 ~ 2001-01-19
    OF - Director → CIF 0
    Williams, Andrew James, Dr
    Individual (1 offspring)
    Officer
    1999-05-28 ~ 2000-03-01
    OF - Secretary → CIF 0
  • 2
    Batty, Elizabeth Pamela
    Clinical Director born in January 1964
    Individual (2 offsprings)
    Officer
    2024-01-23 ~ 2025-06-13
    OF - Director → CIF 0
  • 3
    Mcnish, Andrew Edward
    Solicitor born in October 1966
    Individual (2 offsprings)
    Officer
    2015-11-16 ~ 2025-06-13
    OF - Director → CIF 0
  • 4
    Singh, Sukh Dave, Professor
    Doctor born in December 1967
    Individual (3 offsprings)
    Officer
    2004-12-20 ~ 2025-06-13
    OF - Director → CIF 0
  • 5
    Morton-morys, Andrea
    Born in October 1969
    Individual (3 offsprings)
    Officer
    2025-06-13 ~ now
    OF - Director → CIF 0
  • 6
    Turland, Kevin John
    Born in March 1969
    Individual (38 offsprings)
    Officer
    2025-06-13 ~ now
    OF - Director → CIF 0
  • 7
    Deansgate Company Formations Limited
    Individual (2 offsprings)
    Officer
    1999-05-28 ~ 1999-05-28
    OF - Nominee Director → CIF 0
  • 8
    Fielding, Benjamin James
    Individual (1 offspring)
    Officer
    2000-03-01 ~ 2001-05-21
    OF - Secretary → CIF 0
  • 9
    Barber, Philip Vernon, Dr
    Physician born in February 1946
    Individual (3 offsprings)
    Officer
    2000-11-20 ~ 2025-06-13
    OF - Director → CIF 0
  • 10
    Niven, Robert Mclay, Dr
    Doctot Of Medicine born in October 1959
    Individual (2 offsprings)
    Officer
    2005-01-01 ~ 2024-01-23
    OF - Director → CIF 0
  • 11
    Woodcock, Ashley Arthur, Professor
    Professor Of Medicine born in April 1951
    Individual (8 offsprings)
    Officer
    2015-11-16 ~ 2025-06-13
    OF - Director → CIF 0
  • 12
    Pickering, Charles Anthony Cary, Professor
    Respiratory Physician born in February 1942
    Individual (3 offsprings)
    Officer
    1999-05-28 ~ 2018-09-01
    OF - Director → CIF 0
  • 13
    Vestbo, Jorgen, Professor
    Professor Of Respiratory Medicine born in January 1959
    Individual (3 offsprings)
    Officer
    2018-12-19 ~ 2025-06-13
    OF - Director → CIF 0
  • 14
    Britannia Company Formations Limited
    Individual (2 offsprings)
    Officer
    1999-05-28 ~ 1999-05-28
    OF - Nominee Secretary → CIF 0
  • 15
    Webb, Anthony Kevin
    Physician born in December 1946
    Individual (5 offsprings)
    Officer
    2000-11-20 ~ 2018-09-01
    OF - Director → CIF 0
  • 16
    Langley, Stephen, Dr
    Medical Director born in February 1960
    Individual (1 offspring)
    Officer
    2003-09-08 ~ 2005-02-14
    OF - Director → CIF 0
  • 17
    Rogers, David
    Ceo born in August 1962
    Individual (4 offsprings)
    Officer
    2003-09-08 ~ 2025-06-13
    OF - Director → CIF 0
    Rogers, David
    Individual (4 offsprings)
    Officer
    2001-05-21 ~ 2025-06-13
    OF - Secretary → CIF 0
  • 18
    Randall, Kerry Louise
    Born in July 1980
    Individual (6 offsprings)
    Officer
    2025-06-13 ~ now
    OF - Director → CIF 0
  • 19
    Bilyard, Kevin George
    Managing Director born in February 1957
    Individual (10 offsprings)
    Officer
    2000-03-01 ~ 2001-03-30
    OF - Director → CIF 0
  • 20
    IQVIA LTD.
    - now 03022416
    QUINTILES LIMITED - 2017-11-03
    QUINTILES SCOTLAND LIMITED - 2000-12-29
    3 Forbury Place, 23 Forbury Road, Reading, United Kingdom
    Active Corporate (16 parents, 50 offsprings)
    Person with significant control
    2025-06-13 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 21
    Nwlc, Southmoor Road, Manchester, England
    Corporate (1 offspring)
    Person with significant control
    2016-04-06 ~ 2025-06-13
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
  • 22
    JTC (UK) LIMITED
    - now 04301763 05714981
    JTC MAYFAIR LIMITED - 2006-07-19
    STEVTON (NO.218) LIMITED - 2001-12-04
    The Scalpel, 18th Floor, 52 Lime Street, London, England
    Active Corporate (42 parents, 521 offsprings)
    Officer
    2025-06-27 ~ now
    OF - Secretary → CIF 0
parent relation
Company in focus

MEDICINES EVALUATION UNIT LIMITED

Period: 1999-05-28 ~ now
Company number: 03779957
Registered name
MEDICINES EVALUATION UNIT LIMITED - now
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Par Value of Share
Class 1 ordinary share
12024-04-01 ~ 2025-03-31
Class 2 ordinary share
12024-04-01 ~ 2025-03-31
Class 3 ordinary share
12024-04-01 ~ 2025-03-31
Turnover/Revenue
18,188,618 GBP2024-04-01 ~ 2025-03-31
18,166,529 GBP2023-04-01 ~ 2024-03-31
Cost of Sales
-7,977,897 GBP2024-04-01 ~ 2025-03-31
-7,509,622 GBP2023-04-01 ~ 2024-03-31
Gross Profit/Loss
10,210,721 GBP2024-04-01 ~ 2025-03-31
10,656,907 GBP2023-04-01 ~ 2024-03-31
Administrative Expenses
-4,587,095 GBP2024-04-01 ~ 2025-03-31
-4,502,885 GBP2023-04-01 ~ 2024-03-31
Operating Profit/Loss
5,623,626 GBP2024-04-01 ~ 2025-03-31
6,154,022 GBP2023-04-01 ~ 2024-03-31
Other Interest Receivable/Similar Income (Finance Income)
971,615 GBP2024-04-01 ~ 2025-03-31
273,893 GBP2023-04-01 ~ 2024-03-31
Profit/Loss on Ordinary Activities Before Tax
6,032,655 GBP2024-04-01 ~ 2025-03-31
7,086,083 GBP2023-04-01 ~ 2024-03-31
Profit/Loss
5,339,721 GBP2024-04-01 ~ 2025-03-31
7,360,585 GBP2023-04-01 ~ 2024-03-31
Comprehensive Income/Expense
5,339,721 GBP2024-04-01 ~ 2025-03-31
7,360,585 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
3,123,573 GBP2025-03-31
3,252,637 GBP2024-03-31
Fixed Assets - Investments
33 GBP2025-03-31
6,925,385 GBP2024-03-31
Fixed Assets
3,123,606 GBP2025-03-31
10,178,022 GBP2024-03-31
Debtors
4,590,399 GBP2025-03-31
6,740,061 GBP2024-03-31
Cash at bank and in hand
33,216,149 GBP2025-03-31
19,504,181 GBP2024-03-31
Current Assets
37,806,548 GBP2025-03-31
26,244,242 GBP2024-03-31
Net Current Assets/Liabilities
35,221,510 GBP2025-03-31
23,890,285 GBP2024-03-31
Total Assets Less Current Liabilities
38,345,116 GBP2025-03-31
34,068,307 GBP2024-03-31
Net Assets/Liabilities
38,296,895 GBP2025-03-31
34,020,086 GBP2024-03-31
Equity
Called up share capital
975 GBP2025-03-31
975 GBP2024-03-31
975 GBP2023-03-31
Share premium
264,177 GBP2025-03-31
264,177 GBP2024-03-31
264,177 GBP2023-03-31
Retained earnings (accumulated losses)
38,031,743 GBP2025-03-31
33,754,934 GBP2024-03-31
29,345,245 GBP2023-03-31
Equity
38,296,895 GBP2025-03-31
34,020,086 GBP2024-03-31
29,610,397 GBP2023-03-31
Dividends Paid
Retained earnings (accumulated losses)
-1,062,912 GBP2024-04-01 ~ 2025-03-31
-2,950,896 GBP2023-04-01 ~ 2024-03-31
Dividends Paid
-1,062,912 GBP2024-04-01 ~ 2025-03-31
-2,950,896 GBP2023-04-01 ~ 2024-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
5,339,721 GBP2024-04-01 ~ 2025-03-31
7,360,585 GBP2023-04-01 ~ 2024-03-31
Wages/Salaries
6,874,030 GBP2024-04-01 ~ 2025-03-31
6,181,738 GBP2023-04-01 ~ 2024-03-31
Social Security Costs
726,340 GBP2024-04-01 ~ 2025-03-31
624,781 GBP2023-04-01 ~ 2024-03-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
289,635 GBP2024-04-01 ~ 2025-03-31
263,810 GBP2023-04-01 ~ 2024-03-31
Staff Costs/Employee Benefits Expense
7,890,005 GBP2024-04-01 ~ 2025-03-31
7,070,329 GBP2023-04-01 ~ 2024-03-31
Average Number of Employees
1602024-04-01 ~ 2025-03-31
1492023-04-01 ~ 2024-03-31
Director Remuneration
663,735 GBP2024-04-01 ~ 2025-03-31
483,116 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
238,761 GBP2024-04-01 ~ 2025-03-31
243,793 GBP2023-04-01 ~ 2024-03-31
Audit Fees/Expenses
15,600 GBP2024-04-01 ~ 2025-03-31
8,000 GBP2023-04-01 ~ 2024-03-31
Current Tax for the Period
692,934 GBP2024-04-01 ~ 2025-03-31
-252,284 GBP2023-04-01 ~ 2024-03-31
Tax Expense/Credit at Applicable Tax Rate
1,508,164 GBP2024-04-01 ~ 2025-03-31
1,771,521 GBP2023-04-01 ~ 2024-03-31
Dividends Paid on Shares
1,062,912 GBP2024-04-01 ~ 2025-03-31
2,950,896 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,020,186 GBP2025-03-31
944,065 GBP2024-03-31
Furniture and fittings
589,084 GBP2025-03-31
570,612 GBP2024-03-31
Land and buildings, Long leasehold
5,019,210 GBP2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
891,326 GBP2025-03-31
832,373 GBP2024-03-31
Furniture and fittings
503,820 GBP2025-03-31
470,495 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
58,953 GBP2024-04-01 ~ 2025-03-31
Furniture and fittings
33,325 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Land and buildings, Long leasehold
2,898,914 GBP2025-03-31
3,040,828 GBP2024-03-31
Plant and equipment
128,860 GBP2025-03-31
111,692 GBP2024-03-31
Furniture and fittings
85,264 GBP2025-03-31
100,117 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Motor vehicles
6,959 GBP2025-03-31
6,959 GBP2024-03-31
Computers
262,392 GBP2025-03-31
247,288 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
6,897,831 GBP2025-03-31
6,788,134 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
6,959 GBP2025-03-31
6,959 GBP2024-03-31
Computers
251,857 GBP2025-03-31
247,288 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
3,774,258 GBP2025-03-31
3,535,497 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
4,569 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
238,761 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Computers
10,535 GBP2025-03-31
Trade Debtors/Trade Receivables
Current
850,268 GBP2025-03-31
3,539,918 GBP2024-03-31
Amounts Owed by Group Undertakings
Current
564,239 GBP2024-03-31
Other Debtors
Current
34,250 GBP2024-03-31
Amount of corporation tax that is recoverable
Current
495,043 GBP2025-03-31
495,043 GBP2024-03-31
Called-up share capital (not paid)
Current
110,916 GBP2024-03-31
Prepayments/Accrued Income
Current
1,087,680 GBP2025-03-31
548,525 GBP2024-03-31
Debtors
Amounts falling due within one year, Current
4,590,399 GBP2025-03-31
Current, Amounts falling due within one year
6,740,061 GBP2024-03-31
Trade Creditors/Trade Payables
Current
67,149 GBP2025-03-31
32,677 GBP2024-03-31
Corporation Tax Payable
Current
692,934 GBP2025-03-31
Other Taxation & Social Security Payable
Current
220,711 GBP2025-03-31
147,892 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
1,446,893 GBP2025-03-31
1,971,370 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
160,165 GBP2025-03-31
133,866 GBP2024-03-31
Between one and five year
350,923 GBP2025-03-31
354,115 GBP2024-03-31
More than five year
235,213 GBP2025-03-31
304,512 GBP2024-03-31
All periods
746,301 GBP2025-03-31
792,493 GBP2024-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
48,221 GBP2025-03-31
48,221 GBP2024-03-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
48,221 GBP2025-03-31
48,221 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
828 shares2025-03-31
Class 2 ordinary share
39 shares2025-03-31
Class 3 ordinary share
108 shares2025-03-31
Profit/Loss
Retained earnings (accumulated losses)
5,339,721 GBP2024-04-01 ~ 2025-03-31
  • MEDICINES EVALUATION UNIT LIMITED
    Info
    Registered number 03779957
    3 Forbury Place, 23 Forbury Road, Reading, United Kingdom RG1 3JH
    PRIVATE LIMITED COMPANY incorporated on 1999-05-28 (26 years 11 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-05-28
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.